Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry R Sumnall

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Addiction (Abingdon, England)|November 21, 2017
The harm reduction impact of cryptomarkets: inequality and opportunityHarry R Sumnall
Journal of Psychopharmacology (Oxford, England)|October 18, 2013
The New Zealand new psychoactive substances regime--a step in the right direction, but questions still remainHarry R Sumnall
The International Journal on Drug Policy|August 30, 2022
Encouraging a 'generational shift' in the UKs relationship with drugs. A commentary on the new UK drug strategy. What can be achieved with drug prevention?Harry R Sumnall
Addiction (Abingdon, England)|October 28, 2018
Rat Park: How a rat paradise changed the narrative of addictionSuzanne H Gage, Harry R Sumnall
Neuroscience and Biobehavioral Reviews|June 6, 2003
The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA)Jon C Cole, Harry R Sumnall
Journal of Psychopharmacology (Oxford, England)|January 27, 2005
Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysisHarry R Sumnall, Jon C Cole
Journal of Epidemiology and Community Health|October 16, 2007
Can health campaigns make people ill? The iatrogenic potential of population-based cannabis preventionHarry R Sumnall, Mark A Bellis
Journal of Psychopharmacology (Oxford, England)|January 13, 2006
The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasyHarry R Sumnall, Jon C Cole, Lisa Jerome
Psychopharmacology|July 12, 2002
Methodological problems with ecstasy and the SCL-90Jon C Cole, Harry R Sumnall, Graham F Wagstaff
Journal of Psychopharmacology (Oxford, England)|April 27, 2004
Self-reported psychopathology in polydrug usersHarry R Sumnall, Graham F Wagstaff, Jon C Cole
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Addiction (Abingdon, England)|November 21, 2017
The harm reduction impact of cryptomarkets: inequality and opportunityHarry R Sumnall
Journal of Psychopharmacology (Oxford, England)|October 18, 2013
The New Zealand new psychoactive substances regime--a step in the right direction, but questions still remainHarry R Sumnall
The International Journal on Drug Policy|August 30, 2022
Encouraging a 'generational shift' in the UKs relationship with drugs. A commentary on the new UK drug strategy. What can be achieved with drug prevention?Harry R Sumnall
Addiction (Abingdon, England)|October 28, 2018
Rat Park: How a rat paradise changed the narrative of addictionSuzanne H Gage, Harry R Sumnall
Neuroscience and Biobehavioral Reviews|June 6, 2003
The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA)Jon C Cole, Harry R Sumnall
Journal of Psychopharmacology (Oxford, England)|January 27, 2005
Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysisHarry R Sumnall, Jon C Cole
Journal of Epidemiology and Community Health|October 16, 2007
Can health campaigns make people ill? The iatrogenic potential of population-based cannabis preventionHarry R Sumnall, Mark A Bellis
Journal of Psychopharmacology (Oxford, England)|January 13, 2006
The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasyHarry R Sumnall, Jon C Cole, Lisa Jerome
Psychopharmacology|July 12, 2002
Methodological problems with ecstasy and the SCL-90Jon C Cole, Harry R Sumnall, Graham F Wagstaff
Journal of Psychopharmacology (Oxford, England)|April 27, 2004
Self-reported psychopathology in polydrug usersHarry R Sumnall, Graham F Wagstaff, Jon C Cole
Pageof 4